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ABSTRACT
Background: We currently use the depression subscale (HADD) of the Hospital Anxiety and Depression Scale
(HADS) for depression screening in elderly inpatients. Given recent concerns about the performance of the
HADD in this age group, we performed a quality-control study retrospectively comparing HADD with the
diagnosis of depression by a psychiatrist. We also studied the effect of dementia on the scale’s performance.
Methods: HADS produces two 7-item subscales assessing depression or anxiety. The HADD was administered
by a neuropsychologist. As “gold standard” we considered the psychiatrist’s diagnosis based on the Diagnostic
and Statistical Manual of Mental Disorders, Fourth Edition, criteria. Patients older than 65 years, assessed by
both the HADD and the psychiatrist, with a clinical dementia rating (CDR) score lower than 3, were included.
The effect of dementia was assessed by forming three groups according to the CDR score (CDR0–0.5,
CDR1, and CDR2). Simple and multiple logistic regression models were applied to predict the psychiatrist’s
depression diagnosis from HADD scores. Areas under the receiver operating characteristics curve (AUC)
were plotted and compared by χ2 tests.
Results: On both univariate and multiple analyses, HADD predicted depression diagnosis but performed
poorly (univariate: p = 0.009, AUC = 0.60 (95% confidence interval (CI) = 0.53–0.66); multiple: p = 0.007,
AUC = 0.65 (95% CI = 0.58–0.71)), regardless of cognitive status. Because mood could have changed
between the two assessments (they occurred at different points of the hospital stay), the multiple analyses
were repeated after limiting time interval at 28, 21, and 14 days. No major improvements were noted.
Conclusion: The HADD performed poorly in elderly inpatients regardless of cognitive status. It cannot be
recommended in this population for depression screening without further study.
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Introduction
Depression is common in older individuals
(Samaras et al., 2010). Its prevalence is approxi-
mately 13% in general and 2% for the major
depression subtype (Beekman et al., 1999).
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Depression prevalence further increases among
elderly patients with dementia. Globally, up to
35% develop depression during the disease course
(Aalten et al., 2005) but estimates may vary
according to the dementia type: 30%–50% for
Alzheimer’s disease (AD; Zubenko et al., 2003;
Burgut et al., 2006; Starkstein and Mizrahi,
2006), 52%–63% for vascular dementia (VD;
Moretti et al., 2006), 20%–65% for Lewy body
dementia (LBD; Burgut et al., 2006), and 20%–
45% for Parkinson disease (PD; Burgut et al.,
2006).
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Depression remains underdiagnosed and under-
treated in the elderly, particularly in patients with
dementia (Lang et al., 2010). It is associated with
faster cognitive decline and may interfere with neu-
ropsychological testing, confounding dementia
diagnosis (Lyketsos et al., 2003; Starkstein and
Mizrahi, 2006). For these reasons, depression is
frequently screened for in our hospital memory con-
sultation using the depression subscale (HADD)
of the Hospital Anxiety and Depression Scale
(HADS). The choice of the HADD was based on
the scale’s simplicity, characteristics, and satisfying
metric properties in younger populations. The
HADS was initially developed to identify “caseness”
(possible and probable) of anxiety and depression
among patients in non-psychiatric wards (Zigmond
and Snaith, 1983). Since then, its use has been
extended to outpatient and community settings
(Dunbar et al., 2000; Caci et al., 2003). The
HADS is a well-accepted (Herrmann, 1997),
easy-to-use, 14-item auto-questionnaire producing
two 7-item subscales assessing either depression
(HADD) or anxiety (HADA; Herrmann, 1997;
Bjelland et al., 2002; Poole and Morgan, 2006).
It is a self-assessment based on symptoms over
the preceding week and is rated on a four-point
Likert scale, with a maximum score of 21 on
each subscale (higher scores correspond to higher
disease severity; Johnston et al., 2000; Herrero
et al., 2003). The HADD subscale is constructed
mostly around the item of anhedonia (Poole and
Morgan, 2006). Importantly, it deliberately leaves
out physical indicators of psychological distress
such as dizziness, lethargy, headaches, insomnia,
and fatigue, to prevent interference with somatic
disorders and, thus, may be particularly suited
for the detection of depression in the elderly
(Herrmann, 1997; Bjelland et al., 2002; Wang
et al., 2006). Symptoms of severe psychopathology
are also omitted to avoid the “floor effect”
frequently encountered in non-psychiatric patients
(Herrmann, 1997; Bjelland et al., 2002). The scale
has a high internal consistency with a Cronbach’s α
coefficient of 0.7–0.9 (Herrmann, 1997; Aben et al.,
2002; Bjelland et al., 2002; Herrero et al., 2003;
Lowe et al., 2004; Bambauer et al., 2005; Thomas
et al., 2005). Two-week test–retest reliability is
also high (r > 0.80), demonstrating a satisfying
stability of the scale (Herrmann, 1997). In younger
populations, concurrent validity between HADD
and other depression scales is generally satisfactory,
with correlation coefficients ranging from 0.6 to 0.8
(Bjelland et al., 2002).
However, a recent study suggested a poorer
performance in older populations. Helvik et al.
(2011) reported a modest correlation (Spearman
coefficient 0.51) between the HADD and the
Montgomery–Åsberg Depression Rating Scale
(MADRS), although the MADRS has been well
validated for the detection of depression in patients
with dementia (Leontjevas et al., 2009; Helvik et al.,
2011).
In a quality-control context, we retrospectively
compared scores on the HADD with a psychiatric
diagnosis of depression in older inpatients assessed
during the same hospital stay by both a memory
specialist and a psychiatrist. In this paper, we
report our findings on the efficiency of the scale
for depression screening, as well as the effect
of dementia on the scale’s performance. To our
knowledge, these issues have never been addressed
in this population.
Methods
This is a retrospective study comparing the
scores obtained on the HADD during a memory
consultation with a depression diagnosis made
by the consulting psychiatrist. The study was
conducted in the geriatrics ward of a university
hospital as part of a quality-control project and was
approved by the local ethics committee.
We reviewed the medical files of all inpatients
assessed by our memory consultant between 2001
and 2006. Inclusion criteria comprised:
1. Age older than 65.
2. Assessment by a psychiatrist during the same
hospital stay and psychiatric diagnosis available.
3. Scores available on the HADD and the Clinical
Dementia Rating (CDR) scale (Hughes et al.,
1982).
Patients with severe dementia (CDR score of 3)
were excluded.
Psychiatric and memory assessments were
requested by the treating resident, according to
clinical suspicion for cognitive and psychiatric
disorders. The HADD was used by neuropsycho-
logists for depression screening during the memory
consultation. Because reading comprehension and
visual impairments are frequent in this population,
to ensure item comprehension the HADD was
administered to the patient by the neuropsycho-
logist in all of the cases. The memory specialist
established a diagnosis and attributed a score of
0–3 on the CDR scale, according to the severity of
dementia. The psychiatric diagnosis was established
according to the Diagnostic and Statistical Manual
of Mental Disorders, Fourth Edition. The same
highly experienced psychiatrist evaluated all cases
and the neuropsychologists performed the HADD
independent of the psychiatric evaluation. The
score on the HADD was compared with the
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diagnosis made by the consulting psychiatrist using
the latter as a “gold standard.”
The effect of dementia on the performance of the
HADD was examined by dividing the total sample
into three groups according to the CDR score –
no dementia: CDR0–0.5; early dementia: CDR1;
moderate dementia: CDR2.
Because we used a convenience sample, to assess
for potential selection bias we compared the group
of patients included with those excluded from the
study for sociodemographic and clinical variables.
Finally, psychiatric and cognitive assessments
occurred at different points during the patient’s
hospital stay. To test for a possible bias related to
changes in the patient’s clinical state, we repeated
the analyses restricting the time difference between
the two assessments to 28, 21, and 14 days.
Statistical analyses
Group comparisons were performed using the
χ2 test, unpaired t-test, or Mann–Whitney U
test, as appropriate. Simple and multiple logistic
regression models were applied to predict the
presence of depression diagnosis using HADD
scores while adjusting for age, sex, cognitive
status (CDR), and delay between assessments
(determined by the absolute value of difference
between the two assessment dates). Areas under
the receiver operating characteristics curve (ROC)
were plotted and used as measures of HADD’s
performance (a value of 0.5 corresponding to a
useless test no different from random, and a value
of 1 to the perfect test with 100% sensitivity
and specificity). Areas under curves (AUC) were
compared by χ2 tests. Specificity, sensitivity values,
percentage of correctly classified cases, and most
appropriate HADD cut-off score were calculated
in univariate analysis for the whole group and
the three subgroups (CDR0–0.5, CDR1, and
CDR2). The same cut-off score was applied in
multiple logistic regression analyses for the whole
group to recalculate specificity, sensitivity values,
and correctly classified cases. Multiple logistic
regression analyses were repeated for the whole
group limiting time difference between the two
assessments to 28, 21, and 14 days, and for the
three subgroups (CDR0–0.5, CDR1, and CDR2)
without time limitation.
All analyses were performed using Stata release
12 (College Station, TX).
Results
From 2001 to 2006, 1,795 inpatients were
evaluated in the memory consultation, of which
427 patients were assessed by both the memory
specialist and the psychiatrist during the same
hospital stay. Twelve patients were excluded
because of a score of 3 on the CDR scale.
Another 143 patients did not meet inclusion criteria
(unavailable data for one or more of the CDR score,
HADD score, and psychiatric diagnosis). A total of
272 patients were finally included in the study. We
compared the included group with the 1,523 non-
included patients. The sex distribution was identical
(p = 0.365). The age of the selected group was one
year younger (p = 0.0027). The CDR distribution
was statistically different (p < 0.001) between the
two groups (included: 24.6%, 45.6%, and 29.8%
vs. excluded: 17.3%, 40.2%, and 42.6%, for CDR:
0–0.5, 1, and 2, respectively).
Of the included patients, 108 (39.7%) were
diagnosed with depression by the consulting
psychiatrist. Fifty patients had an episode of
mild depression occurring in the context of
a known bipolar disorder for one patient, a
recurrent depressive disorder for 12 patients, and an
adjustment disorder for another 19 patients. Thirty-
one patients had a depressive episode described as
moderate, of which half in the context of recurrent
depression. Eight patients were diagnosed with a
severe depression, of which one with psychotic
symptoms and three in the context of recurrent
depression. Finally, for 19 patients the type and
severity of the depressive episode were not specified.
Table 1 shows the demographic and clinical
characteristics of the included patients. Both groups
(depressed and non-depressed) were similar, except
for significantly higher HADD scores (p = 0.009)
and higher delays (p = 0.004) between the two
assessments in the depressed group.
In a univariate analysis for the total sample,
the HADD was significantly correlated with the
presence of depression (p = 0.009; Table 2).
However, sensitivity and specificity were both low
(50.9% and 69.5%, respectively) using the generally
accepted threshold score of 8 on the HADD
(Zigmond and Snaith, 1983) and fewer than two-
thirds of the cases were correctly classified. In the
subgroup analysis, the HADD score was correlated
to depression only in the non-demented group
(p = 0.044; Table 2). The AUC was similar in all
three groups (p = 0.802; Table 2).
In a multiple regression analysis of the
total sample, after adjustment for age, sex,
delay, and dementia severity (CDR score), the
HADD was significantly correlated with the
presence of depression but performance remained
modest (p = 0.007, AUC = 0.65 (95% confidence
interval (CI) = 0.58–0.71); sensitivity = 62.0%,
specificity = 63%) (Table 3). Higher time intervals
between psychiatric and memory assessments
were significantly related to the presence of
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Table 1. Demographic and clinical characteristics (n= 272)
T O T A L SA M P L E DE P R E S S E D NO N-D E P R E S S E D
(n = 272) (n = 108) (n = 164) p
....................................................................................................................................................................................................................................................................................................
Age, mean (SD), years 83 (5.8) 83.4 (5.2) 82.8 (5.2) 0.382∗
Male/female 73/199 26/82 47/117 0.404∗∗
CDR (%) 0.061∗∗∗
0–0.5 67 (24.6) 33 (30.6) 34 (20.7)
1 124 (45.6) 48 (44.4) 76 (46.3)
2 81 (29.8) 27 (25) 54 (33)
MMSE, mean (SD) 20.4 (4.5) 20.9 (4.2) 20.2 (4.7) 0.208∗
HADS, mean (SD) 14.5 (6.4) 15.6 (6.6) 13.8 (6.2) 0.022∗
HADD, mean (SD) 6.6 (4) 7.4 (4.1) 6.1 (3.8) 0.009∗
HADA, mean (SD) 7.9 (3.9) 8.2 (4) 7.7 (3.9) 0.294∗
Delay (days), mean (SD) (date
psychiatry–date memory)
9.9 (35.5) 17.1 (26.9) 5.2 (39.6) 0.004∗
∗Student’s t-test; ∗∗Chi-square test; ∗∗∗Mann–Whitney U test.
CDR = Clinical Dementia Rating; HADS = Hospital Anxiety and Depression Scale; HADA = Hospital Anxiety and Depression
scale, Anxiety subscale; HADD = Hospital Anxiety and Depression scale, Depression subscale; MMSE = mini-Mental State
Examination; SD = standard deviation.
Table 2. Performance of the HADD for depression detection: univariate analysis
CUT-OFF ≥ 8
S E N S I T I V I T Y SP E C I FI C I T Y C O R R E C T L Y
n p AUC (95% CI) (%) (%) C L A S S I FI E D (%)
.....................................................................................................................................................................................................................................................................................................................
Total sample 272 0.009 0.60 (0.53–0.66) 50.9 69.5 62.1
CDR0–0.5 67 0.044 0.63 (0.50–0.77) 54.6 73.5 64.2
CDR1 124 0.065 0.59 (0.49–0.69) 47.9 67.1 59.7
CDR2 81 0.502 0.57 (0.43–0.71) 51.9 70.4 64.2
AUC = Areas Under Curve; CDR = Clinical Dementia Rating; CI = Confidence Interval; HADD = Hospital Anxiety and Depression
scale, Depression subscale.
Table 3. Performance of the HADD for depression detection. Multiple regression analysis (dementia severity
according to CDR, age, sex, and delay) for the total population, and by delay limits (28, 21, and 14 days)
CUT-OFF ≥ 8
S E N S I T I V I T Y SP E C I FI C I T Y C O R R E C T L Y
n p AUC (95% CI) (%) (%) C L A S S I FI E D (%)
.....................................................................................................................................................................................................................................................................................................................
Total sample 272 0.007 0.65 (0.58–0.71) 62.0 60.3 61.0
≤ 28 days 208 0.031 0.64 (0.56–0.72) 57.7 57.7 57.7
≤ 21 days 183 0.067 0.65 (0.57–0.73) 56.7 56.9 56.8
≤ 14 days 134 0.047 0.68 (0.59–0.77) 64.7 63.9 64.2
AUC = Areas Under Curve; CDR = Clinical Dementia Rating; CI = Confidence Interval; HADD = Hospital Anxiety and Depression
scale, Depression subscale.
depression (p = 0.010). However, there was no
major improvement in the scale’s performance
when analyses were repeated after limiting the
interval between the two assessments to 28, 21, and
14 days (Table 3).
In a multiple analysis for each CDR group after
adjustment for age, sex, and delay between the
two assessments, the HADD score significantly
predicted depression only for the non-demented
group and there was a trend toward significance
for mild dementia cases (CDR0–0.5: p = 0.047,
CDR1: p = 0.054, and CDR2: p = 0.266). AUC
were calculated on ROC curves for the three
groups (CDR0–0.5: AUC = 0.64 (95% CI = 0.51–
0.78); CDR1: AUC = 0.62 (95% CI = 0.52–0.72);
CDR2: AUC = 0.67 (95% CI = 0.54–0.79)). The
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difference among AUC was not statistically
significant (p = 0.837).
Discussion
To our knowledge, this study is the first to compare
the HADD with a psychiatric assessment for
depression screening in older inpatients. Moreover,
it is the first to study the effect of dementia presence
and severity on the scale’s performance.
The most widely accepted HADD threshold for
depression screening is eight (Zigmond and Snaith,
1983; Bjelland et al., 2002), for which sensitivity
and specificity in the literature vary between 70%
and 90% (Aben et al., 2002; Bjelland et al., 2002;
Lowe et al., 2004; Bambauer et al., 2005). In
our study, the ROC curve also indicated that
the above cut-off score was the most appropriate.
Nevertheless, sensitivity, specificity, and accuracy
were far lower than those described in younger
populations, strongly suggesting that the HADD
should not be used in the hospitalized elderly.
Furthermore, AUCs were significantly low (0.60–
0.65) compared with the value of 0.8 generally
preferred in clinical tests, or those reported in
younger populations (0.81–0.96; Aben et al., 2002;
Bambauer et al., 2005; Rodgers et al., 2005;
Poole and Morgan, 2006). Importantly, analysis
by CDR group revealed only minor changes in
the performance of the HADD and similar AUCS
between the three groups, indicating that the
modest performance of this scale in our study
population was not strongly related to the presence
of dementia.
Our study has several limitations. First, the
depressed group included patients with various
subtypes and only eight patients had severe forms
of depression. Thus, we have insufficient power to
report the performance of the HADD for severe
depression. However, because screening tools such
as the HADD are mostly used to identify cases that
might otherwise go clinically undetected, its rather
low sensitivity and inability to reliably detect milder
cases is the most serious concern. Second, the delay
between the psychiatric and neuropsychological
evaluations was at times quite long and some of
the depressed cases may have sufficiently improved
between the two assessments to score negatively on
the HADD. To take into account this potentially
significant bias, we repeated the multiple regression
analyses in three sub-samples including only cases
with a maximum delay between assessments of 28,
21, and 14 days. The AUC remained low in all
three groups, suggesting that the relatively poor
performance of the HADD was not strongly related
to the above delay. Although sensitivity, specificity,
and accuracy improved with shorter delays, their
values also remained low, even in the group with
a delay of 14 days or fewer, thus confirming
that delay was not the main reason for the
disappointing performance of the HADD. Finally,
in keeping with a quality-control investigation, we
used a convenience sample that included only
cases that received both cognitive and psychiatric
evaluations. This sample was not meant to be
representative of all patients assessed in the memory
consultation, but differences with non-included
patients were minor. Moreover, some cases with
very mild cognitive or depressive symptoms for
whom psychiatric and memory assessments were
not requested by the treating resident might have
been inappropriately excluded from the study.
In our experience, the HADD did not perform
well in older hospitalized patients both with or
without dementia. Further prospective studies are
warranted to explore this issue and to compare the
HADD with other depression scales that have been
developed for use in the elderly.
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